Abstract
The term frontotemporal dementia (FTD) describes a clinically, genetically and pathologically diverse group of neurodegenerative disorders. Symptoms ofFTDcan present in individuals in their 20s through to their 90s, but the mean age at onset is in the sixth decade. The most common presentation is with a change in personality and impaired social conduct (behavioural variantFTD). Less frequently patients present with language problems (primary progressive aphasia). Both of these groups of patients can develop motor features consistent with either motor neuron disease (usually the amyotrophic lateral sclerosis variant) or parkinsonism (most commonly a progressive supranuclear palsy or corticobasal syndrome). In about a third of casesFTDis familial, with mutations in the progranulin, microtubule‐associated protein tau and chromosome 9 open reading frame 72 genes being the major causes. Mutations in a number of other genes includingTANK‐binding kinase 1 are rare causes of familialFTD. This review aims to clarify the often confusing terminology ofFTD, and outline the various clinical features and diagnostic criteria of sporadic and familialFTDsyndromes. It will also discuss the current major challenges inFTDresearch and clinical practice, and potential areas for future research. image This review clarifies the terminology of frontotemporal dementia (FTD) and summarizes the various clinical features and most recent diagnostic criteria of sporadic and familial FTD syndromes. It also discusses the current major challenges in FTD research and clinical practice, and highlights potential areas for future research.This article is part of the Frontotemporal Dementia special issue.
Funding Information
  • Medical Research Council
  • National Institute on Handicapped Research

This publication has 281 references indexed in Scilit: